|
These nonopioids
|
may interact with ...
|
to cause...
|
|
Salicylates
|
Acetaminophen
|
renal toxicity
|
| Oral
anticoagulatants (Warfarin) |
bleeding/hemorrage
|
| Probenecid |
interference
with uricosuric effects of probencid (aspirin has this effect) |
| Methotrexate |
inhibition
of renal excretion of methotrexate, resulting in hepatotoxicity &
bone marrow suppression |
| Alcohol |
increased
GI irritation & bleeding |
| Hypoglycemic
medications |
hypoglyemia
(higher doses of aspirin with insulin may have this effect) |
|
|
|
NSAIDs
|
tricyclic antidepressants
|
increased effect
of antidepressant due to decreased clearance from body
|
| Lithium |
increased serum / plasma lithium concentrations and reduced renal
lithium excretion, causing possible lithium toxicity |
| Digoxin |
increased
effects of digoxin, which may cause toxicity |
| Salicylates |
decreased
anti-inflammatory effect of these drugs & may also increase risk
of GI ulceration & bleeding |
| Cyclosporin |
increased
risk & severity of renal impairment |
| Corticosteroids |
increased risk of GI ulceration & bleeding |
| Loop
diuretics |
decreased
diuretic effect |
- ACE inhibitors
- Beta-adrenergic
blockers
- Thiazide
diuretics (hydralazine, prazosin)
|
Use
of any of these drugs with NSAIDs for longer than 3 days may lead
to a decrease in the antihypertensive effect of these drugs and/or
an increased risk of impaired kidney function. |
|
|
|
Acetaminophen
|
Isoniazid
|
increased
hepatoxic effects of acetaminophen
|
- Barbiturates
- OralContraceptives
- Anticholinergics
- Hydantoins
(e.g. phenytoin)
- carbamazepine
- rifampin
- sulfinpyrazone
|
increased
risk of hepatotoxicity, while theanalgesic/ antipyretic effectiveness
of acetaminophen may be decreased. |
|
|